Company Filing History:
Years Active: 2023
Title: Innovations by Marcus Carstensen in Gamma Brain Stimulation
Introduction
Marcus Carstensen is an innovative inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of brain stimulation technology, particularly in the treatment of Alzheimer's disease and sleep disorders. His work focuses on the use of light and sound to enhance therapeutic outcomes for patients.
Latest Patents
Marcus Carstensen holds a patent for a "Gamma stimulation pulsing light source system with dosage adjustment for gaze angle." This invention aims to prevent or treat Alzheimer's disease and sleeping disorders through the application of light. The system utilizes a strobing 40 Hz light source, which has been shown to produce positive effects through stimulation. The invention emphasizes the importance of knowing the actual dosage of light entering a person's eyes to understand the relationship between dosage and effectiveness. A camera is employed to detect various factors, including the subject's gaze angle, distance, and pupil diameter, which can affect the light power entering the eye. The system allows for adjustments in session duration based on these factors, ensuring that the final dosage received by the individual is consistent and meets the target dosage set by medical professionals.
Career Highlights
Marcus Carstensen is associated with Optoceutics Aps, where he continues to develop and refine his innovative technologies. His work has the potential to significantly impact the treatment of cognitive disorders, providing new avenues for patient care.
Collaborations
Some of his notable coworkers include Paul Michael Petersen and Jes Broeng, who contribute to the collaborative efforts at Optoceutics Aps.
Conclusion
Marcus Carstensen's innovative work in gamma brain stimulation represents a significant advancement in the treatment of Alzheimer's disease and sleep disorders. His patented technology showcases the potential of light-based therapies in improving patient outcomes.